|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 8/23/21 Huake Holding Biology Co., Ltd. F-1/A 12:3.1M EdgarAgents LLC/FA |
Document/Exhibit Description Pages Size
1: F-1/A Amendment No. 1 to Form F-1 HTML 1.20M
2: EX-10.6 The Purchase and Advance Payment Agreements by and HTML 65K
Between Aokai Fa and Suppliers
3: EX-10.8 Form of Director Offer Letter With Our Directors HTML 26K
4: EX-21.1 List of Subsidiaries HTML 8K
5: EX-23.1 Consent of Prager Metis CPAs, LLC HTML 7K
12: EX-99.10 Charter of Nomination and Corporate Governance HTML 23K
Committee
6: EX-99.4 Consent of Long Yi HTML 7K
7: EX-99.5 Consent of Henry Wang HTML 7K
8: EX-99.6 Consent of Yongju Wang HTML 7K
9: EX-99.7 Consent of Chen Cheng HTML 7K
10: EX-99.8 Charter of Audit Committee HTML 37K
11: EX-99.9 Charter of Compensation Committee HTML 18K
Exhibit 99.7
CONSENT OF DIRECTOR NOMINEE
Huake Holding Biology Co., LTD. (the “Company”) intends to file a Registration Statement on Form F-1 (together with any amendments or supplements thereto, the “Registration Statement”) registering securities for issuance in its public offering. As required by Rule 438 under the Securities Act of 1933, as amended, the undersigned hereby consents to being named in the Registration Statement as a Director Nominee.
Dated: August 23, 2021
| /s/ Chen Cheng | |
| Chen Cheng |
| This ‘F-1/A’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 8/23/21 | None on these Dates | ||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 6/29/21 Huake Holding Biology Co., Ltd. F-1 10:2.5M EdgarAgents LLC/FA |